C57BL/6JCya-Rassf10em1/Cya
Common Name
Rassf10-KO
Product ID
S-KO-15207
Backgroud
C57BL/6JCya
Strain ID
KOCMP-78748-Rassf10-B6J-VA
When using this mouse strain in a publication, please cite “Rassf10-KO Mouse (Catalog S-KO-15207) were purchased from Cyagen.”
Product Type
Age
Genotype
Sex
Quantity
Basic Information
Strain Name
Rassf10-KO
Strain ID
KOCMP-78748-Rassf10-B6J-VA
Gene Name
Product ID
S-KO-15207
Gene Alias
4632411J06Rik
Background
C57BL/6JCya
NCBI ID
Modification
Conventional knockout
Chromosome
Chr 7
Phenotype
Datasheet
Application
--
Strain Description
Ensembl Number
ENSMUST00000182858
NCBI RefSeq
NM_175279
Target Region
Exon 1
Size of Effective Region
~2.1 kb
Overview of Gene Research
RASSF10, a member of the Ras-association domain family, is often regarded as a tumor-suppressor gene. It contains a RA (Ras-association) and two coiled domains. RASSF10 is involved in multiple biological pathways such as cell cycle control, apoptosis, and epithelial-mesenchymal transition (EMT), and its abnormal methylation can impact tumor-related processes [3,1].
In Ras-association domain family 10 (Rassf10) knockout mice, Rassf10 haploinsufficiency promotes neoplasia formation in Rassf1A-/-and p53-/-mouse cancer models, increasing the incidence of diseases like lymphoma and thymoma. In human kidney cancer, RASSF10 is frequently epigenetically inactivated by CpG island promoter hypermethylation, correlating with decreased survival and progressed disease state [2]. In esophageal squamous cell carcinoma (ESCC), overexpression of RASSF10 reduces cell growth, colony formation, migration, and invasion, and is associated with inactivation of the Wnt/β-catenin pathway [1].
In conclusion, RASSF10 functions as a tumor suppressor, influencing processes like neoplasia formation, cell growth, and metastasis across various cancers. The Rassf10 knockout mouse models have been crucial in revealing its role in cancer-related disease conditions, highlighting its potential as a diagnostic, prognostic biomarker, and a candidate for targeted therapy.
References:
1. Liu, Yifei, Zhu, Xiaohui, Zhang, Wenwen, Feng, Jia, Shi, Jiahai. 2022. RASSF10 exhibits tumor‑suppressing potential involving tumor proliferation, metastasis and epithelial‑mesenchymal transition in esophageal squamous cell carcinoma. In Oncology reports, 47, . doi:10.3892/or.2022.8291. https://pubmed.ncbi.nlm.nih.gov/35211758/
2. Richter, Antje M, Woods, Michelle L, Küster, Miriam M, Boettger, Thomas, Dammann, Reinhard H. 2020. RASSF10 is frequently epigenetically inactivated in kidney cancer and its knockout promotes neoplasia in cancer prone mice. In Oncogene, 39, 3114-3127. doi:10.1038/s41388-020-1195-6. https://pubmed.ncbi.nlm.nih.gov/32047266/
3. Richter, Antje M, Küster, Miriam M, Woods, Michelle L, Krueger, Marcus, Dammann, Reinhard H. 2019. RASSF10 Is a TGFβ-Target That Regulates ASPP2 and E-Cadherin Expression and Acts as Tumor Suppressor That Is Epigenetically Downregulated in Advanced Cancer. In Cancers, 11, . doi:10.3390/cancers11121976. https://pubmed.ncbi.nlm.nih.gov/31817988/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.